Effects of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, on lipid profiling in patients with type 2 diabetes

Authors: G Ruotolo, K.D Roth, P.L Milligan, Y Lin, J.M Wilson, V Pirro, K.L Duffin, A Haupt

Published: 2020-11-26

DOI: 10.1093/ehjci/ehaa946.3056

Source: Full article